*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Prof. Dennis Liotta, Emory University
New Therapies for Treating Cancer and Inflammation
The combined efforts of chemists, pharmacologists and biochemists at Emory have successfully resulted in the development of novel and selective preclinical and clinical agents of biomedical interest. I will briefly describe two ongoing projects involving collaborations with Emory University School of Medicine faculty that have resulted in the identification of novel small molecules targeted to proteins of high biomedical interest. These include analogs of the natural product, triptolide, as well as synthetic analogs that modulate several important signal transduction processes.
For more information contact Prof. Stefan France (404-385-1796).
